Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
about
Somatic mosaicism in the human genomeDifferential diagnoses of overgrowth syndromes: the most important clinical and radiological disease manifestationsSomatic mosaicism: implications for disease and transmission geneticsEvidence for SH2 domain-containing 5'-inositol phosphatase-2 (SHIP2) contributing to a lymphatic dysfunctionOvergrowth Syndromes.New insights into the generation and role of de novo mutations in health and diseaseNext-Generation Sequencing in Intellectual DisabilityPIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluationLymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CAPost-zygotic Point Mutations Are an Underrecognized Source of De Novo Genomic VariationSomatic Activating PIK3CA Mutations Cause Venous MalformationProteus syndrome review: molecular, clinical, and pathologic featuresGenetics of lymphatic anomaliesRepublished: Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetimeNon-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetimeSomatic mutation, genomic variation, and neurological diseasePostzygotic single-nucleotide mosaicisms in whole-genome sequences of clinically unremarkable individualsA Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasiaExome capture from saliva produces high quality genomic and metagenomic dataMegalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutationsHypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brainGermline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP)--pure coincidence?Malformations of cortical development: clinical features and genetic causesAKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation.A somatic MAP3K3 mutation is associated with verrucous venous malformationPI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.Assessment of copy number variations in the brain genome of schizophrenia patients.Pediatric lymphatic malformations: evolving understanding and therapeutic options.Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumoursPhosphoinositide 3-kinase: a new kid on the block in vascular anomalies.Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular AnomaliesSomatic gain-of-function mutations in PIK3CA in patients with macrodactyly.Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsyIdentification and Characterization of a Novel Constitutional PIK3CA Mutation in a Child Lacking the Typical Segmental Overgrowth of "PIK3CA-Related Overgrowth Spectrum".
P2860
Q26823199-AFA3DFAB-636B-4D5D-80DA-56CA74FFCA5CQ27002915-2C5C6777-6B97-4DE6-A98B-B36F78725D26Q27016060-DABF566A-BB77-4A5D-987D-9F9CF9F367CEQ27329602-29047DC1-B5E4-438E-8658-C2158AECF146Q27691998-12933F34-5208-4D19-8D46-6FBDBC007CF6Q28073446-0E5F0771-3D4A-4D40-A3ED-285A8ACEDEE3Q28080074-B4748F4E-6048-4133-A996-BDDE71CAB27BQ28081443-14AA44E9-8980-4C35-99FE-14974EFB8228Q28256964-8B5BA204-43AA-421F-A33C-F320F0BC7AA8Q28263098-577A0883-30AC-451C-89D3-BAD4FA9ECE62Q28270654-C3C40FA6-F769-4972-98CE-8E67C14EA02EQ28297663-C7227089-EDE3-4E00-859B-FEE4BFD8A918Q28308201-C17EEA27-35C0-4023-B920-9B1199126D7FQ28385687-9C035FEE-F931-4941-8EDB-CECED375E76EQ28392579-F7A0D0DB-EC47-4E1A-9099-02692D26D1A1Q28395313-FA3E32B9-021D-4BD2-A6C7-7D0436C67984Q28397138-EC4F6246-252F-4F29-BFD6-DCA60A12D7E4Q30252766-EF35DBC1-533E-4BCA-8E71-9F28BE72C207Q30300538-C0D730F8-7248-41C5-A008-9FFDDAE5686FQ30795243-E2A43578-9EED-484E-9379-824740551C6CQ31150058-8A444835-DF15-40A7-8C58-A26934339608Q33846446-6BC36162-6256-42C8-8402-D83B4418DB9CQ34339712-82081891-6BFE-4829-9808-AF5EA78CBFCEQ34743417-1D306EE9-19CE-495F-9ECC-17748DDFA1BDQ35079964-4FB2875C-1539-484A-B418-F9003FCFEFCBQ35188898-D4E40469-71A2-42A6-A7AC-E2A7AE906F2EQ35196528-EF53DB9D-0BC5-45BF-B047-D6C42F4D8711Q35221916-DE1976D3-0308-4F7B-A8AA-0DCFFC7925EBQ35260766-058C4EC4-794C-4F75-9F7A-00B8D610DF57Q35542297-017677C4-865D-4E11-8F18-BCEF2808DDA7Q35600539-6B64D39B-A0A7-4C39-B4BF-1AA42BE2FCB1Q35753306-789AB5C4-CC58-4583-A9A2-5D365893DDE5Q35805267-7F46DAAD-FEA3-4AE8-920E-843CD8408B01Q35905671-1CE0CCEF-2F7C-4A00-8920-657E53FA757AQ35993050-E8D9BF4B-4B9E-410F-8215-E832EF7A67E2Q36117648-5CE0131C-BE70-426B-8827-93AD2693F2FBQ36518788-26DCB5EB-5CD7-4E95-A0F3-2C850B2B76D6Q36525854-F6D95B41-A156-49D6-92B9-CFCE11F080BDQ36552676-4D5C07E8-5165-45D1-8F3A-21A3EFFD91B7Q36576691-251A94AC-6E56-4D55-8797-2C983CF0EB89
P2860
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@ast
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@en
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@nl
type
label
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@ast
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@en
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@nl
prefLabel
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@ast
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@en
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@nl
P2093
P2860
P3181
P1476
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
@en
P2093
Guilherme L Yamamoto
Harry P W Kozakewich
John B Mulliken
Kyle C Kurek
Matthew L Warman
Samantha A Spencer
Steven J Fishman
Ugur M Ayturk
Valerie L Luks
P2860
P304
P3181
P356
10.1016/J.AJHG.2012.05.006
P407
P577
2012-06-08T00:00:00Z